The Clorox Company (NYSE:CLX) Shares Sold by Impax Asset Management Group plc

Impax Asset Management Group plc trimmed its position in shares of The Clorox Company (NYSE:CLX) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,485 shares of the company’s stock after selling 2,687 shares during the quarter. Impax Asset Management Group plc’s holdings in Clorox were worth $8,225,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CLX. Huntington National Bank boosted its holdings in Clorox by 4.2% during the third quarter. Huntington National Bank now owns 13,786 shares of the company’s stock worth $2,246,000 after buying an additional 559 shares in the last quarter. Oppenheimer & Co. Inc. lifted its holdings in shares of Clorox by 1.6% in the third quarter. Oppenheimer & Co. Inc. now owns 17,310 shares of the company’s stock valued at $2,820,000 after purchasing an additional 268 shares in the last quarter. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Clorox by 45.0% in the third quarter. Victory Capital Management Inc. now owns 323,612 shares of the company’s stock valued at $52,720,000 after purchasing an additional 100,453 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC lifted its holdings in shares of Clorox by 3.9% in the third quarter. Ashton Thomas Private Wealth LLC now owns 6,738 shares of the company’s stock valued at $1,098,000 after purchasing an additional 254 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is currently owned by insiders.

Clorox Stock Performance

Shares of CLX stock opened at $167.69 on Friday. The company’s fifty day simple moving average is $162.39 and its 200-day simple moving average is $147.34. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $169.09. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market cap of $20.76 billion, a PE ratio of 58.43, a P/E/G ratio of 3.06 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the firm posted $0.49 EPS. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. As a group, equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.91%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.04%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI reduced their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Barclays boosted their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research report on Friday, September 6th. Finally, JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.